Just as a new COVID strain ravages Europe, the Indian drug regulator has approved two vaccine candidates for use in differing capacities. One is based on the Oxford-AstraZeneca vaccine, produced by the Serum Institute of India, called Covishield. The second vaccine, Covaxin has been developed by homegrown company Bharat Biotech in association with ICMR (Indian Council of Medical Research).
